WO2023028730A1 - Use of aloesone in preparation of product for resisting oxidative stress injury - Google Patents
Use of aloesone in preparation of product for resisting oxidative stress injury Download PDFInfo
- Publication number
- WO2023028730A1 WO2023028730A1 PCT/CN2021/115228 CN2021115228W WO2023028730A1 WO 2023028730 A1 WO2023028730 A1 WO 2023028730A1 CN 2021115228 W CN2021115228 W CN 2021115228W WO 2023028730 A1 WO2023028730 A1 WO 2023028730A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- pine
- oxidative stress
- aloe
- preparation
- aloesone
- Prior art date
Links
- 230000006378 damage Effects 0.000 title claims abstract description 18
- 238000002360 preparation method Methods 0.000 title claims abstract description 11
- 230000036542 oxidative stress Effects 0.000 title claims abstract description 10
- JHELBXAAAYUKCT-UHFFFAOYSA-N aloesone Chemical compound C1=C(O)C=C2OC(CC(=O)C)=CC(=O)C2=C1C JHELBXAAAYUKCT-UHFFFAOYSA-N 0.000 title abstract description 13
- 208000027418 Wounds and injury Diseases 0.000 title abstract description 5
- 208000014674 injury Diseases 0.000 title abstract description 5
- 239000003814 drug Substances 0.000 claims abstract description 7
- 230000013227 macrophage apoptotic process Effects 0.000 claims abstract description 6
- 201000010099 disease Diseases 0.000 claims abstract description 5
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims abstract description 5
- 229940079593 drug Drugs 0.000 claims abstract description 5
- 235000011399 aloe vera Nutrition 0.000 claims description 45
- 235000008331 Pinus X rigitaeda Nutrition 0.000 claims description 38
- 235000011613 Pinus brutia Nutrition 0.000 claims description 38
- 241000018646 Pinus brutia Species 0.000 claims description 38
- 235000002961 Aloe barbadensis Nutrition 0.000 claims description 24
- 244000186892 Aloe vera Species 0.000 claims description 24
- 241001116389 Aloe Species 0.000 claims description 21
- 230000003078 antioxidant effect Effects 0.000 claims description 14
- 230000035882 stress Effects 0.000 claims description 8
- 239000000463 material Substances 0.000 claims description 3
- 230000002265 prevention Effects 0.000 claims description 2
- HHEAADYXPMHMCT-UHFFFAOYSA-N dpph Chemical compound [O-][N+](=O)C1=CC([N+](=O)[O-])=CC([N+]([O-])=O)=C1[N]N(C=1C=CC=CC=1)C1=CC=CC=C1 HHEAADYXPMHMCT-UHFFFAOYSA-N 0.000 abstract description 11
- 230000000694 effects Effects 0.000 abstract description 4
- 230000002000 scavenging effect Effects 0.000 abstract description 4
- 230000003064 anti-oxidating effect Effects 0.000 abstract description 2
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 39
- 150000003254 radicals Chemical class 0.000 description 20
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 18
- 210000004027 cell Anatomy 0.000 description 15
- 239000003642 reactive oxygen metabolite Substances 0.000 description 13
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 12
- 239000002158 endotoxin Substances 0.000 description 12
- 229920006008 lipopolysaccharide Polymers 0.000 description 12
- 239000001301 oxygen Substances 0.000 description 12
- 229910052760 oxygen Inorganic materials 0.000 description 12
- 210000002540 macrophage Anatomy 0.000 description 11
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 10
- 239000012141 concentrate Substances 0.000 description 9
- -1 superoxide anion radicals Chemical class 0.000 description 9
- 238000006243 chemical reaction Methods 0.000 description 8
- 239000002904 solvent Substances 0.000 description 8
- 238000004440 column chromatography Methods 0.000 description 7
- 239000000284 extract Substances 0.000 description 7
- 239000000047 product Substances 0.000 description 7
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 6
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 6
- JGFZNNIVVJXRND-UHFFFAOYSA-N N,N-Diisopropylethylamine (DIPEA) Chemical compound CCN(C(C)C)C(C)C JGFZNNIVVJXRND-UHFFFAOYSA-N 0.000 description 6
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 6
- 239000003963 antioxidant agent Substances 0.000 description 6
- 235000006708 antioxidants Nutrition 0.000 description 6
- 150000001875 compounds Chemical class 0.000 description 6
- 239000000203 mixture Substances 0.000 description 6
- XDFNWJDGWJVGGN-UHFFFAOYSA-N 2-(2,7-dichloro-3,6-dihydroxy-9h-xanthen-9-yl)benzoic acid Chemical compound OC(=O)C1=CC=CC=C1C1C2=CC(Cl)=C(O)C=C2OC2=CC(O)=C(Cl)C=C21 XDFNWJDGWJVGGN-UHFFFAOYSA-N 0.000 description 5
- ABRVLXLNVJHDRQ-UHFFFAOYSA-N [2-pyridin-3-yl-6-(trifluoromethyl)pyridin-4-yl]methanamine Chemical compound FC(C1=CC(=CC(=N1)C=1C=NC=CC=1)CN)(F)F ABRVLXLNVJHDRQ-UHFFFAOYSA-N 0.000 description 5
- 238000002835 absorbance Methods 0.000 description 5
- 230000006907 apoptotic process Effects 0.000 description 5
- 239000003208 petroleum Substances 0.000 description 5
- 239000000243 solution Substances 0.000 description 5
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 5
- VHYFNPMBLIVWCW-UHFFFAOYSA-N 4-Dimethylaminopyridine Chemical compound CN(C)C1=CC=NC=C1 VHYFNPMBLIVWCW-UHFFFAOYSA-N 0.000 description 4
- 229940126062 Compound A Drugs 0.000 description 4
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 4
- NLDMNSXOCDLTTB-UHFFFAOYSA-N Heterophylliin A Natural products O1C2COC(=O)C3=CC(O)=C(O)C(O)=C3C3=C(O)C(O)=C(O)C=C3C(=O)OC2C(OC(=O)C=2C=C(O)C(O)=C(O)C=2)C(O)C1OC(=O)C1=CC(O)=C(O)C(O)=C1 NLDMNSXOCDLTTB-UHFFFAOYSA-N 0.000 description 4
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 4
- 230000001640 apoptogenic effect Effects 0.000 description 4
- LVTJOONKWUXEFR-FZRMHRINSA-N protoneodioscin Natural products O(C[C@@H](CC[C@]1(O)[C@H](C)[C@@H]2[C@]3(C)[C@H]([C@H]4[C@@H]([C@]5(C)C(=CC4)C[C@@H](O[C@@H]4[C@H](O[C@H]6[C@@H](O)[C@@H](O)[C@@H](O)[C@H](C)O6)[C@@H](O)[C@H](O[C@H]6[C@@H](O)[C@@H](O)[C@@H](O)[C@H](C)O6)[C@H](CO)O4)CC5)CC3)C[C@@H]2O1)C)[C@H]1[C@H](O)[C@H](O)[C@H](O)[C@@H](CO)O1 LVTJOONKWUXEFR-FZRMHRINSA-N 0.000 description 4
- BIAAQBNMRITRDV-UHFFFAOYSA-N 1-(chloromethoxy)-2-methoxyethane Chemical compound COCCOCCl BIAAQBNMRITRDV-UHFFFAOYSA-N 0.000 description 3
- 210000000170 cell membrane Anatomy 0.000 description 3
- 238000000684 flow cytometry Methods 0.000 description 3
- 238000003760 magnetic stirring Methods 0.000 description 3
- 238000000034 method Methods 0.000 description 3
- 238000002156 mixing Methods 0.000 description 3
- OIPPWFOQEKKFEE-UHFFFAOYSA-N orcinol Chemical compound CC1=CC(O)=CC(O)=C1 OIPPWFOQEKKFEE-UHFFFAOYSA-N 0.000 description 3
- 238000003756 stirring Methods 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 2
- TZCPCKNHXULUIY-RGULYWFUSA-N 1,2-distearoyl-sn-glycero-3-phosphoserine Chemical compound CCCCCCCCCCCCCCCCCC(=O)OC[C@H](COP(O)(=O)OC[C@H](N)C(O)=O)OC(=O)CCCCCCCCCCCCCCCCC TZCPCKNHXULUIY-RGULYWFUSA-N 0.000 description 2
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- 108010040476 FITC-annexin A5 Proteins 0.000 description 2
- ZWZWYGMENQVNFU-UHFFFAOYSA-N Glycerophosphorylserin Natural products OC(=O)C(N)COP(O)(=O)OCC(O)CO ZWZWYGMENQVNFU-UHFFFAOYSA-N 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 2
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 description 2
- 238000010521 absorption reaction Methods 0.000 description 2
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 2
- WTEOIRVLGSZEPR-UHFFFAOYSA-N boron trifluoride Chemical compound FB(F)F WTEOIRVLGSZEPR-UHFFFAOYSA-N 0.000 description 2
- 230000008030 elimination Effects 0.000 description 2
- 238000003379 elimination reaction Methods 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- MHMNJMPURVTYEJ-UHFFFAOYSA-N fluorescein-5-isothiocyanate Chemical compound O1C(=O)C2=CC(N=C=S)=CC=C2C21C1=CC=C(O)C=C1OC1=CC(O)=CC=C21 MHMNJMPURVTYEJ-UHFFFAOYSA-N 0.000 description 2
- 230000007760 free radical scavenging Effects 0.000 description 2
- IXCSERBJSXMMFS-UHFFFAOYSA-N hydrogen chloride Substances Cl.Cl IXCSERBJSXMMFS-UHFFFAOYSA-N 0.000 description 2
- 229910000041 hydrogen chloride Inorganic materials 0.000 description 2
- 230000003834 intracellular effect Effects 0.000 description 2
- 239000001630 malic acid Substances 0.000 description 2
- 235000011090 malic acid Nutrition 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 239000012528 membrane Substances 0.000 description 2
- 230000001590 oxidative effect Effects 0.000 description 2
- 230000000144 pharmacologic effect Effects 0.000 description 2
- 230000004224 protection Effects 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 229920006395 saturated elastomer Polymers 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- UCSJYZPVAKXKNQ-HZYVHMACSA-N streptomycin Chemical compound CN[C@H]1[C@H](O)[C@@H](O)[C@H](CO)O[C@H]1O[C@@H]1[C@](C=O)(O)[C@H](C)O[C@H]1O[C@@H]1[C@@H](NC(N)=N)[C@H](O)[C@@H](NC(N)=N)[C@H](O)[C@H]1O UCSJYZPVAKXKNQ-HZYVHMACSA-N 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- LMDZBCPBFSXMTL-UHFFFAOYSA-N 1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide Substances CCN=C=NCCCN(C)C LMDZBCPBFSXMTL-UHFFFAOYSA-N 0.000 description 1
- FPQQSJJWHUJYPU-UHFFFAOYSA-N 3-(dimethylamino)propyliminomethylidene-ethylazanium;chloride Chemical compound Cl.CCN=C=NCCCN(C)C FPQQSJJWHUJYPU-UHFFFAOYSA-N 0.000 description 1
- AFHJQYHRLPMKHU-XXWVOBANSA-N Aloin Natural products O=C1c2c(O)cc(CO)cc2[C@H]([C@H]2[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O2)c2c1c(O)ccc2 AFHJQYHRLPMKHU-XXWVOBANSA-N 0.000 description 1
- 108050008874 Annexin Proteins 0.000 description 1
- 102000000412 Annexin Human genes 0.000 description 1
- 108090000672 Annexin A5 Proteins 0.000 description 1
- 102000004121 Annexin A5 Human genes 0.000 description 1
- 201000001320 Atherosclerosis Diseases 0.000 description 1
- 229910015900 BF3 Inorganic materials 0.000 description 1
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 1
- 208000024172 Cardiovascular disease Diseases 0.000 description 1
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 description 1
- MYMOFIZGZYHOMD-UHFFFAOYSA-N Dioxygen Chemical compound O=O MYMOFIZGZYHOMD-UHFFFAOYSA-N 0.000 description 1
- 239000006144 Dulbecco’s modified Eagle's medium Substances 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 108090000371 Esterases Proteins 0.000 description 1
- 206010019851 Hepatotoxicity Diseases 0.000 description 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 1
- 208000013016 Hypoglycemia Diseases 0.000 description 1
- 241000234280 Liliaceae Species 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- CBENFWSGALASAD-UHFFFAOYSA-N Ozone Chemical compound [O-][O+]=O CBENFWSGALASAD-UHFFFAOYSA-N 0.000 description 1
- 229930182555 Penicillin Natural products 0.000 description 1
- JGSARLDLIJGVTE-MBNYWOFBSA-N Penicillin G Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)CC1=CC=CC=C1 JGSARLDLIJGVTE-MBNYWOFBSA-N 0.000 description 1
- 244000269722 Thea sinensis Species 0.000 description 1
- 102000004142 Trypsin Human genes 0.000 description 1
- 108090000631 Trypsin Proteins 0.000 description 1
- ZEEBGORNQSEQBE-UHFFFAOYSA-N [2-(3-phenylphenoxy)-6-(trifluoromethyl)pyridin-4-yl]methanamine Chemical compound C1(=CC(=CC=C1)OC1=NC(=CC(=C1)CN)C(F)(F)F)C1=CC=CC=C1 ZEEBGORNQSEQBE-UHFFFAOYSA-N 0.000 description 1
- SAHIZENKTPRYSN-UHFFFAOYSA-N [2-[3-(phenoxymethyl)phenoxy]-6-(trifluoromethyl)pyridin-4-yl]methanamine Chemical compound O(C1=CC=CC=C1)CC=1C=C(OC2=NC(=CC(=C2)CN)C(F)(F)F)C=CC=1 SAHIZENKTPRYSN-UHFFFAOYSA-N 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 150000001335 aliphatic alkanes Chemical class 0.000 description 1
- 125000003545 alkoxy group Chemical group 0.000 description 1
- CPUHNROBVJNNPW-UHFFFAOYSA-N aloin A Natural products OC1C(O)C(O)C(CO)OC1OC1C2=CC(CO)=CC(O)=C2C(=O)C2=C(O)C=CC=C21 CPUHNROBVJNNPW-UHFFFAOYSA-N 0.000 description 1
- AFHJQYHRLPMKHU-WEZNYRQKSA-N aloin B Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1[C@H]1C2=CC(CO)=CC(O)=C2C(=O)C2=C(O)C=CC=C21 AFHJQYHRLPMKHU-WEZNYRQKSA-N 0.000 description 1
- PYKYMHQGRFAEBM-UHFFFAOYSA-N anthraquinone Natural products CCC(=O)c1c(O)c2C(=O)C3C(C=CC=C3O)C(=O)c2cc1CC(=O)OC PYKYMHQGRFAEBM-UHFFFAOYSA-N 0.000 description 1
- 150000004056 anthraquinones Chemical class 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 230000000259 anti-tumor effect Effects 0.000 description 1
- 230000002155 anti-virotic effect Effects 0.000 description 1
- 235000010323 ascorbic acid Nutrition 0.000 description 1
- 229960005070 ascorbic acid Drugs 0.000 description 1
- 239000011668 ascorbic acid Substances 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 239000012148 binding buffer Substances 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 239000000460 chlorine Substances 0.000 description 1
- 229910052801 chlorine Inorganic materials 0.000 description 1
- 229940125904 compound 1 Drugs 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 231100000673 dose–response relationship Toxicity 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 235000018927 edible plant Nutrition 0.000 description 1
- 238000003912 environmental pollution Methods 0.000 description 1
- 210000002615 epidermis Anatomy 0.000 description 1
- 239000012091 fetal bovine serum Substances 0.000 description 1
- 238000002073 fluorescence micrograph Methods 0.000 description 1
- 230000023597 hemostasis Effects 0.000 description 1
- 230000007686 hepatotoxicity Effects 0.000 description 1
- 231100000304 hepatotoxicity Toxicity 0.000 description 1
- 238000006897 homolysis reaction Methods 0.000 description 1
- 239000001257 hydrogen Substances 0.000 description 1
- 229910052739 hydrogen Inorganic materials 0.000 description 1
- 230000002218 hypoglycaemic effect Effects 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 230000005865 ionizing radiation Effects 0.000 description 1
- 230000002427 irreversible effect Effects 0.000 description 1
- AFHJQYHRLPMKHU-UHFFFAOYSA-N isobarbaloin Natural products OC1C(O)C(O)C(CO)OC1C1C2=CC(CO)=CC(O)=C2C(=O)C2=C(O)C=CC=C21 AFHJQYHRLPMKHU-UHFFFAOYSA-N 0.000 description 1
- 230000031700 light absorption Effects 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 239000002609 medium Substances 0.000 description 1
- 238000006241 metabolic reaction Methods 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 230000001338 necrotic effect Effects 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 230000004792 oxidative damage Effects 0.000 description 1
- 230000001575 pathological effect Effects 0.000 description 1
- 229940049954 penicillin Drugs 0.000 description 1
- 239000012466 permeate Substances 0.000 description 1
- 238000006303 photolysis reaction Methods 0.000 description 1
- 230000015843 photosynthesis, light reaction Effects 0.000 description 1
- 230000004962 physiological condition Effects 0.000 description 1
- 150000008442 polyphenolic compounds Chemical class 0.000 description 1
- 235000013824 polyphenols Nutrition 0.000 description 1
- 239000013641 positive control Substances 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 238000001953 recrystallisation Methods 0.000 description 1
- 239000000523 sample Substances 0.000 description 1
- 238000010186 staining Methods 0.000 description 1
- 239000012192 staining solution Substances 0.000 description 1
- 239000012086 standard solution Substances 0.000 description 1
- 229960005322 streptomycin Drugs 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 238000010189 synthetic method Methods 0.000 description 1
- DKVBOUDTNWVDEP-NJCHZNEYSA-N teicoplanin aglycone Chemical compound N([C@H](C(N[C@@H](C1=CC(O)=CC(O)=C1C=1C(O)=CC=C2C=1)C(O)=O)=O)[C@H](O)C1=CC=C(C(=C1)Cl)OC=1C=C3C=C(C=1O)OC1=CC=C(C=C1Cl)C[C@H](C(=O)N1)NC([C@H](N)C=4C=C(O5)C(O)=CC=4)=O)C(=O)[C@@H]2NC(=O)[C@@H]3NC(=O)[C@@H]1C1=CC5=CC(O)=C1 DKVBOUDTNWVDEP-NJCHZNEYSA-N 0.000 description 1
- 238000010998 test method Methods 0.000 description 1
- 239000012588 trypsin Substances 0.000 description 1
- 230000029663 wound healing Effects 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A61P39/06—Free radical scavengers or antioxidants
Definitions
- the invention relates to the field of antioxidants, in particular to the application of aloe vera pine in the preparation of anti-oxidative stress damage products.
- Free radicals are constantly produced in human life activities.
- One is the endogenous free radicals produced by various metabolic reactions in the body; the other is the exogenous free radicals produced by the homolysis of covalent bonds of organic molecules in organisms due to high temperature, ultraviolet rays, photolysis, ionizing radiation, chemical drugs, and environmental pollution.
- free radicals are mainly oxygen free radicals, and the content of oxygen free radicals accounts for about 95%, such as superoxide anion radicals ( ⁇ O 2 - ), alkoxyl groups (RO ⁇ ), hydroperoxyl groups (HOO ⁇ ), alkane Oxygen (ROO ⁇ ), etc.
- oxygen-containing compounds that are easy to lose an electron and become free radicals although the electrons are paired, such as: singlet oxygen (excited oxygen 1 O 2 ), hydrogen peroxide Active oxygen radicals such as (H 2 O 2 ), ozone (O 3 ), and other oxygen-containing substances with the reaction characteristics of oxygen radicals are collectively called reactive oxygen species (ROS).
- ROS reactive oxygen species
- non-oxygen free radicals such as hydrogen free radicals (H ), organic free radicals (R ), reactive nitrogen (RNS) and reactive chlorine (RCS) and so on.
- Aloe is a medicinal and edible plant, which is a perennial evergreen succulent herb of the genus Aloe of the family Liliaceae.
- Aloe vera has pharmacological effects such as anti-inflammatory, anti-oxidation, promotion of wound healing, liver protection, hypoglycemia, hemostasis, anti-tumor and anti-virus.
- anthraquinones are believed to be the antioxidant active components of aloe.
- Aloe pine aloesone
- Aloesone is the aglycon of aloin, and it is also a unique chemical component in the epidermis of aloe. The content of aloe pine in aloe is low and there are few studies on the relevant pharmacological activities.
- the present invention proposes the application of aloe vera pine in the preparation of anti-oxidative stress damage products.
- the aloe vera pine is used in the preparation of anti-oxidative stress damage products, and the aloe vera pine inhibits macrophage apoptosis by clearing ROS to resist oxidative stress damage.
- the anti-oxidative stress damage product is applied to the preparation of drugs for preventing or treating diseases induced by oxidative stress damage.
- the medicine also includes pharmaceutically acceptable auxiliary materials.
- aloe vera pine has the anti-oxidative activity of directly removing active oxygen, can inhibit the generation of active oxygen (ROS) in RAW264. Therefore, aloe vera pine can be used in the preparation of anti-oxidative stress damage products, especially in the preparation of drugs for the prevention and treatment of diseases induced by oxidative stress damage. Moreover, compared with the hepatotoxicity of anthraquinone compounds, which are the antioxidant active ingredients of aloe, the chromone compound aloe vera pine has better safety, and is more conducive to the preparation of safe anti-oxidative stress damage products.
- ROS active oxygen
- Aloe pine reduces lipopolysaccharide-induced ROS levels in macrophages.
- a 1 absorbance of aloe vera pine and DPPH
- a 2 absorbance of aloe vera pine and ethanol
- a 3 absorbance of DPPH and ethanol
- Macrophage RAW264.7 was cultured in 5% CO2 incubator at 37°C in DMEM medium containing 10% fetal bovine serum, 100 U/mL penicillin and 100 ⁇ g/mL streptomycin.
- RAW264.7 cells were plated (24-well plate) at 1.0-2.0 ⁇ 10 5 cells/well for 24 hours and treated with aloe pine (0.1 ⁇ M, 1 ⁇ M, 10 ⁇ M and 100 ⁇ M) for 2 hours. Subsequently, LPS (1 ⁇ g/mL) was applied for 24 hours. After the experiment, the cell supernatant was collected, washed three times with PBS, and then added with 1:1000 diluted DCFH-DA.
- Annexin V-FITC/PI detects the effect of aloe vera pine on macrophage apoptosis induced by lipopolysaccharide
- Aloe pine has DPPH scavenging activity
- DPPH is a stable organic free radical with a strong absorption peak at 517nm. Antioxidants can pair with their single electrons to make their absorption gradually disappear. The change of light absorption value has a quantitative relationship with the number of electrons they accept. The ability to scavenge DPPH can indicate the strength of its antioxidant activity.
- the experimental results show that aloe vera pine can scavenge DPPH free radicals very well, and its IC 50 is 0.73, which is equivalent to the antioxidant activity of natural antioxidant tea polyphenols.
- Aloe pine reduces lipopolysaccharide-induced macrophage ROS level
- DCFH-DA is a general indicator of oxidative stress.
- DCFH-DA itself has no fluorescence and can freely pass through the cell membrane. After entering the cell, it can be hydrolyzed by intracellular esterase to generate DCFH (2',7'-Dichlorodihydrofluorescein, DCFH). However, DCFH cannot permeate the cell membrane, so the probe can be easily loaded into the cell. Intracellular reactive oxygen species can oxidize non-fluorescent DCFH to produce fluorescent DCF. The fluorescence of DCF was detected to determine the level of reactive oxygen species in the cells. In this study, DCFH-DA was used to observe the effect of aloe vera pine on macrophage reactive oxygen species induced by lipopolysaccharide.
- Aloe pine inhibits lipopolysaccharide-induced macrophage apoptosis
- the phosphatidylserine in the membrane is transferred to the outside of the membrane, and the FITC-labeled annexin (Annexin V) can be combined with phosphatidylserine to indicate the early stage of apoptosis; while another staining
- the agent PI can diffuse into the nucleus of apoptotic and necrotic cells and combine with DNA to indicate the late stage of apoptosis.
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Biochemistry (AREA)
- Toxicology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
Disclosed is the use of aloesone in the preparation of a product for resisting oxidative stress injury. The aloesone has anti-oxidation activity of directly scavenging DPPH free radicals, and can scavenge ROS to inhibit macrophage apoptosis and thus resist oxidative stress injury, and therefore can be used to prepare a drug for preventing and treating diseases induced by oxidative stress injury.
Description
本发明涉及抗氧化剂领域,特别涉及芦荟松在制备抗氧化应激损伤产品中应用。The invention relates to the field of antioxidants, in particular to the application of aloe vera pine in the preparation of anti-oxidative stress damage products.
现代研究表明,人的生命活动中不断地产生自由基。一是机体内各种代谢反应产生的内源性自由基;二是由于高温、紫外线、光解、电离辐射、化学药物以及环境污染等导致生物体内有机分子共价键均裂产生的外源性自由基。自由基主要为氧自由基,氧自由基的含量约占95%,如超氧阴离子自由基(·O
2
-)、烷氧基(RO·),氢过氧基(HOO·)、烷过氧基(ROO·)等,另外,还存在许多虽然电子配对,但却易失去一个电子而变为自由基的含氧化合物,例如:单线态氧(激发态氧
1O
2)、过氧化氢(H
2O
2)、臭氧(O
3)等这些活泼的氧自由基与具有氧自由基反应特性的其它含氧物质统称为活性氧(ROS)。其次为非氧自由基,如氢自由基(H·)、有机自由基(R·)、活性氮(RNS)和活性氯(RCS)等。
Modern research shows that free radicals are constantly produced in human life activities. One is the endogenous free radicals produced by various metabolic reactions in the body; the other is the exogenous free radicals produced by the homolysis of covalent bonds of organic molecules in organisms due to high temperature, ultraviolet rays, photolysis, ionizing radiation, chemical drugs, and environmental pollution. free radicals. Free radicals are mainly oxygen free radicals, and the content of oxygen free radicals accounts for about 95%, such as superoxide anion radicals (·O 2 - ), alkoxyl groups (RO·), hydroperoxyl groups (HOO·), alkane Oxygen (ROO·), etc. In addition, there are many oxygen-containing compounds that are easy to lose an electron and become free radicals although the electrons are paired, such as: singlet oxygen (excited oxygen 1 O 2 ), hydrogen peroxide Active oxygen radicals such as (H 2 O 2 ), ozone (O 3 ), and other oxygen-containing substances with the reaction characteristics of oxygen radicals are collectively called reactive oxygen species (ROS). Followed by non-oxygen free radicals, such as hydrogen free radicals (H ), organic free radicals (R ), reactive nitrogen (RNS) and reactive chlorine (RCS) and so on.
在正常的生理状况下,人体生成和消除氧自由基处在一个动态平衡,但是当机体的生成和消除自由基的动态平衡被打破,体内自由基水平增高的时候,因为自由基活泼,有极强的氧化能力,可以通过一系列的氧化反应,破坏细胞的结构与功能,使得机体产生不可逆转的氧化损伤,从而诱发多种病理损伤,如动脉粥样硬化,心血管疾病,糖尿病,肿瘤等。如果能够消除过多的氧化自由基,对于许多自由基引起的及衰老相关疾病都能够预防。所以从植物中寻找安全有效的抗氧化剂成为研究热点之一。Under normal physiological conditions, the body’s production and elimination of oxygen free radicals are in a dynamic balance, but when the dynamic balance of the body’s production and elimination of free radicals is broken and the level of free radicals in the body increases, because the free radicals are active, there will be extreme Strong oxidative ability can destroy the structure and function of cells through a series of oxidation reactions, causing the body to produce irreversible oxidative damage, thereby inducing various pathological injuries, such as atherosclerosis, cardiovascular disease, diabetes, tumors, etc. . If excessive oxidative free radicals can be eliminated, many free radical-induced and aging-related diseases can be prevented. So finding safe and effective antioxidants from plants has become one of the research hotspots.
芦荟为药食两用性植物,来自百合科(liliaceae)芦荟属(aloe)多年生常 绿肉质草本。芦荟具有抗炎、抗氧化、促进伤口愈合、保肝、降糖、止血、抗肿瘤和抗病毒等药理作用。传统认为蒽醌类化合物是芦荟的抗氧化活性成分。芦荟松(aloesone)是芦荟苦素的苷元,也是芦荟表皮中特有的化学成分。芦荟松在芦荟中的含量较低且相关药理活性的研究较少。Aloe is a medicinal and edible plant, which is a perennial evergreen succulent herb of the genus Aloe of the family Liliaceae. Aloe vera has pharmacological effects such as anti-inflammatory, anti-oxidation, promotion of wound healing, liver protection, hypoglycemia, hemostasis, anti-tumor and anti-virus. Traditionally, anthraquinones are believed to be the antioxidant active components of aloe. Aloe pine (aloesone) is the aglycon of aloin, and it is also a unique chemical component in the epidermis of aloe. The content of aloe pine in aloe is low and there are few studies on the relevant pharmacological activities.
芦荟松结构3D图:Aloe pine structure 3D map:
中文名:芦荟松,分子式C
13H
12O
4;分子量:232.23198;英文名:aloesone;其它命名:2-acetonyl-7-hydroxy-5-methylchromone(2-丙酮基-7-羟基-5-甲基-色酮)、2-acetonyl-7-hydroxy-5-methyl-chromen-4-one(2-丙酮基-7-羟基-5-甲基-色烯-4-酮)、2-(2-oxopropyl)-7-hydroxy-5-methyl-4H-1-benzopyran-4-one(2-(2-氧丙基)-7-羟基-5-甲基-4H-1-苯并吡喃-4-酮)、7-hydroxy-5-methyl-2-(2-oxopropyl)chromen-4-one(7-羟基-5-甲基-2-(2-氧丙基)色烯-4-酮)。
Chinese name: Aloe pine, molecular formula C 13 H 12 O 4 ; molecular weight: 232.23198; English name: aloesone; other names: 2-acetonyl-7-hydroxy-5-methylchromone base-chromone), 2-acetonyl-7-hydroxy-5-methyl-chromen-4-one (2-acetonyl-7-hydroxyl-5-methyl-chromen-4-one), 2-(2 -oxopropyl)-7-hydroxy-5-methyl-4H-1-benzopyran-4-one(2-(2-oxopropyl)-7-hydroxy-5-methyl-4H-1-benzopyran- 4-keto), 7-hydroxy-5-methyl-2-(2-oxopropyl)chromen-4-one(7-hydroxy-5-methyl-2-(2-oxopropyl)chromen-4-one ).
发明内容Contents of the invention
鉴于此,本发明提出芦荟松在制备抗氧化应激损伤产品中应用。In view of this, the present invention proposes the application of aloe vera pine in the preparation of anti-oxidative stress damage products.
本发明的技术方案是这样实现的:Technical scheme of the present invention is realized like this:
芦荟松在制备抗氧化应激损伤产品中应用,所述芦荟松通过清除ROS抑制巨噬细胞凋亡来抗氧化应激损伤。The aloe vera pine is used in the preparation of anti-oxidative stress damage products, and the aloe vera pine inhibits macrophage apoptosis by clearing ROS to resist oxidative stress damage.
进一步的,所述抗氧化应激损伤产品应用于制备预防或治疗氧化应激损伤诱发疾病药物。Further, the anti-oxidative stress damage product is applied to the preparation of drugs for preventing or treating diseases induced by oxidative stress damage.
进一步的,所述药物还包括药学上接受的辅料。Further, the medicine also includes pharmaceutically acceptable auxiliary materials.
与现有技术相比,本发明的有益效果是:Compared with prior art, the beneficial effect of the present invention is:
本发明发现芦荟松具有直接清除活性氧的抗氧化活性,能够抑制脂多糖诱导的RAW264.7细胞的活性氧(ROS)生成及其介导的巨噬细胞凋亡,具有较好抗氧化应激损伤,因此可将芦荟松应用于制备抗氧化应激损伤产品,尤其是制备防治氧化应激损伤诱发疾病药物。而且相对于芦荟抗氧化活性成分蒽醌类化合物的肝毒性,色酮类化合物芦荟松具有更好的安全性,更利于制备安全性良好的抗氧化应激损伤产品。The present invention finds that aloe vera pine has the anti-oxidative activity of directly removing active oxygen, can inhibit the generation of active oxygen (ROS) in RAW264. Therefore, aloe vera pine can be used in the preparation of anti-oxidative stress damage products, especially in the preparation of drugs for the prevention and treatment of diseases induced by oxidative stress damage. Moreover, compared with the hepatotoxicity of anthraquinone compounds, which are the antioxidant active ingredients of aloe, the chromone compound aloe vera pine has better safety, and is more conducive to the preparation of safe anti-oxidative stress damage products.
图1.芦荟松降低脂多糖诱发的巨噬细胞ROS水平。Figure 1. Aloe pine reduces lipopolysaccharide-induced ROS levels in macrophages.
A)各组不同物镜下DCF荧光图(×50,×100);A) DCF fluorescence images under different objective lenses in each group (×50,×100);
B)平均荧光强度(流式细胞仪,*与正常对照组比,#与脂多糖处理组组比)B) Mean fluorescence intensity (flow cytometry, *compared with normal control group, #compared with lipopolysaccharide treated group)
图2.芦荟松抑制脂多糖诱发的巨噬细胞凋亡水平。Figure 2. Aloe pine inhibits lipopolysaccharide-induced macrophage apoptosis.
为了更好理解本发明技术内容,下面提供具体实施例,对本发明做进一步的说明。In order to better understand the technical content of the present invention, specific examples are provided below to further illustrate the present invention.
本发明实施例所用的实验方法如无特殊说明,均为常规方法。The experimental methods used in the examples of the present invention are conventional methods unless otherwise specified.
本发明实施例所用的材料、试剂等,如无特殊说明,均可从商业途径得到。The materials and reagents used in the examples of the present invention can be obtained from commercial sources unless otherwise specified.
一、芦荟松合成1. Synthesis of aloe vera pine
1.1芦荟松合成路线1.1 Aloe pine synthetic route
1.2芦荟松的合成方法:1.2 The synthetic method of aloe vera pine:
(1)3,5-二羟基甲苯和乙酸和三氟化硼乙醚按摩尔比10:8:20混合,在80℃油浴下磁力搅拌反应12h。反应完毕后冷却至室温,用乙酸乙酯和水萃取,萃取三次,取乙酸乙酯层,加入到饱和NaHCO
3溶液中,每摩尔3,5-二羟基甲苯加入饱和NaHCO
3溶液体积为1L,将混合物搅拌10min,使溶液中的乙酸反应完全。然后用乙酸乙酯和水萃取,萃取三次,取乙酸乙酯层,减压浓缩除去溶剂,得到浓缩物,加入乙酸乙酯使浓缩物溶解,再加入适量石油醚后静置重结晶,抽滤后得到化合物1-1。
(1) Mix 3,5-dihydroxytoluene with acetic acid and boron trifluoride ether at a molar ratio of 10:8:20, and react with magnetic stirring in an oil bath at 80°C for 12 hours. After the reaction was completed, cool to room temperature, extract with ethyl acetate and water, and extract three times, take the ethyl acetate layer, add it to a saturated NaHCO solution, add 3,5 - dihydroxytoluene to the saturated NaHCO solution to make the volume 1L , The mixture was stirred for 10 min to completely react the acetic acid in the solution. Then extract with ethyl acetate and water, extract three times, take the ethyl acetate layer, concentrate under reduced pressure to remove the solvent, obtain a concentrate, add ethyl acetate to dissolve the concentrate, add an appropriate amount of petroleum ether, stand for recrystallization, and filter with suction Compound 1-1 was obtained.
(2)化合物1-1、二氯甲烷和DIPEA(N,N-二异丙基乙胺)混合,每摩尔化合物1-1加入二氯甲烷体积为3.5L,化合物1-1和DIPEA的摩尔比为1:6.5;冰浴磁力搅拌反应至0℃后,加入MEM-Cl(2-甲氧基乙氧基甲基氯),化合物1-1和MEM-Cl的摩尔比为1:1;室温下磁力搅拌反应12h。反应完毕后用乙酸乙酯和水萃取,萃取三次,取乙酸乙酯层,减压浓缩除去溶剂,得到浓缩物用柱层析(石油醚︰乙酸乙酯=6︰1,v/v)纯化得到化合物1-2,即化合物C。(2) Compound 1-1, dichloromethane and DIPEA (N,N-diisopropylethylamine) are mixed, and the volume of dichloromethane added per mole of compound 1-1 is 3.5L, and the moles of compound 1-1 and DIPEA The ratio is 1:6.5; after the reaction is heated to 0°C with magnetic stirring in an ice bath, MEM-Cl (2-methoxyethoxymethyl chloride) is added, and the molar ratio of compound 1-1 and MEM-Cl is 1:1; Magnetic stirring was carried out at room temperature for 12 h. After the reaction is completed, extract with ethyl acetate and water, extract three times, take the ethyl acetate layer, concentrate under reduced pressure to remove the solvent, and obtain a concentrate that is purified by column chromatography (petroleum ether: ethyl acetate = 6: 1, v/v) Compound 1-2, namely compound C, was obtained.
(3)取化合物C、苹果酸、4-二甲氨基吡啶和二氯甲烷混合,化合物C、苹果酸和4-二甲氨基吡啶的摩尔比为1:1.0:1.0,化合物C和二氯甲烷的摩尔 体积比mol/L为1:4.0;冰浴搅拌反应至0℃后,加入1-乙基-(3-二甲基氨基丙基)碳二亚胺盐酸盐,25℃下搅拌反应6.0h;反应后用二氯甲烷和水萃取,取二氯甲烷层,减压浓缩除去溶剂,得到浓缩物,将浓缩物经柱层析纯化,所述柱层析的溶剂由体积比为6.0:1的石油醚和乙酸乙酯混合制得,得到化合物1-3,即化合物B;(3) Mix compound C, malic acid, 4-dimethylaminopyridine and dichloromethane, the molar ratio of compound C, malic acid and 4-dimethylaminopyridine is 1:1.0:1.0, compound C and dichloromethane The molar volume ratio mol/L is 1:4.0; after stirring the reaction in an ice bath to 0°C, add 1-ethyl-(3-dimethylaminopropyl)carbodiimide hydrochloride, and stir the reaction at 25°C 6.0h; After the reaction, extract with dichloromethane and water, take the dichloromethane layer, concentrate under reduced pressure to remove the solvent, and obtain a concentrate, which is purified by column chromatography, and the solvent of the column chromatography is 6.0 by volume. : Prepared by mixing petroleum ether and ethyl acetate in 1 to obtain compound 1-3, namely compound B;
(4)取化合物B、氢氧化钠和二甲基亚砜混合,化合物B和氢氧化钠的摩尔比为1:2.4,化合物B和二甲基亚砜的摩尔体积比mol/L为1:4.0,25℃下搅拌反应8.0h,反应后用乙酸乙酯和水萃取,取乙酸乙酯层,减压浓缩除去溶剂,得到浓缩物,将浓缩物经柱层析纯化,所述柱层析的溶剂由体积比为5.0:1的石油醚和乙酸乙酯混合制得,得到化合物1-4,即化合物A;(4) Mix compound B, sodium hydroxide and dimethyl sulfoxide, the mol ratio of compound B and sodium hydroxide is 1:2.4, and the molar volume ratio mol/L of compound B and dimethyl sulfoxide is 1: 4.0, stirred and reacted at 25°C for 8.0h, extracted with ethyl acetate and water after the reaction, took the ethyl acetate layer, concentrated under reduced pressure to remove the solvent, and obtained a concentrate, which was purified by column chromatography, the column chromatography The solvent is prepared by mixing petroleum ether and ethyl acetate with a volume ratio of 5.0:1 to obtain compound 1-4, namely compound A;
(5)将化合物A、氯化氢溶液和异丙醇混合,化合物A和氯化氢的摩尔比为1:4.0,异丙醇和化合物A的摩尔比为32.7:1,加热至45℃搅拌反应1.5h;反应后减压浓缩除去溶剂,得到浓缩物,将浓缩物用柱层析纯化,柱层析的溶剂由体积比为5:1的石油醚和乙酸乙酯混合制得;纯化、干燥后得到化合物1-5,即目标产物芦荟松。(5) Mix compound A, hydrogen chloride solution and isopropanol, the molar ratio of compound A to hydrogen chloride is 1:4.0, the molar ratio of isopropanol to compound A is 32.7:1, heat to 45°C and stir for 1.5h; react Afterwards, the solvent was concentrated under reduced pressure to obtain a concentrate, which was purified by column chromatography. The solvent for column chromatography was prepared by mixing petroleum ether and ethyl acetate with a volume ratio of 5:1; after purification and drying, compound 1 was obtained. -5, the target product aloe vera pine.
芦荟松核磁数据:Aloe pine NMR data:
白色固体粉末,
1H NMR(400MHz,D
6)δ10.61(s,1H),6.62(s,1H),6.60(s,1H),6.03(s,1H),3.85(s,2H),2.65(s,3H),2.21(s,3H);
13C NMR(100MHz,D
6)δ202.87,178.22,161.09,160.62,159.27,141.65,116.70,114.39,112.92,100.58,47.58,29.89,22.48.
White solid powder, 1 H NMR(400MHz,D 6 )δ10.61(s,1H),6.62(s,1H),6.60(s,1H),6.03(s,1H),3.85(s,2H), 2.65(s,3H),2.21(s,3H); 13 C NMR(100MHz,D 6 )δ202.87,178.22,161.09,160.62,159.27,141.65,116.70,114.39,112.92,100.58,47.58,29.89.22.
二、应用试验2. Application test
1)试验方法1) Test method
1.DPPH法测定芦荟松对自由基的清除率1. DPPH method to measure the scavenging rate of aloe vera pine to free radicals
取DPPH固体2mg溶于20mL无水乙醇中使其浓度为0.1mg/ml,超声5min,充分振摇,其吸光度在0.6-1.0之间,避光保存。芦荟松用无水乙醇溶解,梯度稀释为5个浓度(2mg/mL、1mg/mL、0.5mg/mL、0.25mg/mL、0.125mg/mL)。于96孔板中每孔各加100uL不同浓度的芦荟松和DPPH溶液,混匀后37℃避光孵育30min,517nm下测定孔板吸光度,同时应用抗坏血酸标准溶液作为阳性对照(0.05mg/mL)。分别以芦荟松浓度为横坐标,自由基清除率为纵坐标,绘制标准曲线并计算IC
50。
Dissolve 2 mg of DPPH solid in 20 mL of absolute ethanol to a concentration of 0.1 mg/ml, sonicate for 5 min, shake fully, the absorbance is between 0.6-1.0, and store in the dark. Aloe vera pine was dissolved in absolute ethanol, and diluted to 5 concentrations (2mg/mL, 1mg/mL, 0.5mg/mL, 0.25mg/mL, 0.125mg/mL). Add 100uL of different concentrations of aloe vera pine and DPPH solutions to each well of a 96-well plate, mix well and incubate at 37°C in the dark for 30min, measure the absorbance of the well plate at 517nm, and use ascorbic acid standard solution as a positive control (0.05mg/mL) . Taking the concentration of aloe vera pine as the abscissa and the free radical scavenging rate as the ordinate, draw a standard curve and calculate the IC 50 .
清除率%=[1-(A
1-A
2)/A
3]*100%
Clearance %=[1-(A 1 -A 2 )/A 3 ]*100%
A
1=芦荟松与DPPH的吸光度
A 1 = absorbance of aloe vera pine and DPPH
A
2=芦荟松与乙醇的吸光度
A 2 = absorbance of aloe vera pine and ethanol
A
3=DPPH与乙醇的吸光度
A 3 = absorbance of DPPH and ethanol
2.DCFH-DA法检测芦荟松对脂多糖诱导的巨噬细胞内活性氧(ROS)清除作用2. DCFH-DA method to detect the scavenging effect of aloe vera pine on the reactive oxygen species (ROS) in macrophages induced by lipopolysaccharide
巨噬细胞RAW264.7采用含10%胎牛血清、100U/mL青霉素和100μg/mL链霉素高糖DMEM培养基,于5%CO2培养箱中37℃培养。RAW264.7细胞以1.0~2.0×10
5个细胞/孔接种铺板(24孔板)24小时后应用芦荟松(0.1μM、1μM、10μM和100μM)处理2小时。随后应用LPS(1μg/mL)处理24小时。实验结束后,收集细胞上清液,应用PBS清洗3次后加入1:1000稀释的DCFH-DA。避光并于37℃培养箱中孵育20分钟。随后PBS洗涤细胞3次,充分去除未进入细胞内的DCFH-DA。通过倒置荧光显微镜(Zeiss X-Cite)进行镜下观察拍照,并应用具有FITC通道的流式细胞术测量平均荧光强度。
Macrophage RAW264.7 was cultured in 5% CO2 incubator at 37°C in DMEM medium containing 10% fetal bovine serum, 100 U/mL penicillin and 100 μg/mL streptomycin. RAW264.7 cells were plated (24-well plate) at 1.0-2.0×10 5 cells/well for 24 hours and treated with aloe pine (0.1 μM, 1 μM, 10 μM and 100 μM) for 2 hours. Subsequently, LPS (1 μg/mL) was applied for 24 hours. After the experiment, the cell supernatant was collected, washed three times with PBS, and then added with 1:1000 diluted DCFH-DA. Protect from light and incubate for 20 minutes in a 37°C incubator. Subsequently, the cells were washed 3 times with PBS to fully remove the DCFH-DA that did not enter the cells. Observation and photographing were carried out by an inverted fluorescence microscope (Zeiss X-Cite), and the average fluorescence intensity was measured by flow cytometry with FITC channel.
3.Annexin V-FITC/PI检测芦荟松对脂多糖诱导的巨噬细胞凋亡的影响3. Annexin V-FITC/PI detects the effect of aloe vera pine on macrophage apoptosis induced by lipopolysaccharide
不同浓度芦荟松处理巨噬细胞后,PBS洗涤2次,应用胰酶裂解,离心收集细胞。加入500μL结合缓冲液,然后依次加入5μL Annexin V-FITC和PI染液,室温孵育5分钟,应用流式细胞仪(Agilent NovoCyte)分析巨噬细胞中早期和晚期凋亡的细胞比例。After macrophages were treated with different concentrations of aloe vera pine, they were washed twice with PBS, lysed with trypsin, and collected by centrifugation. Add 500 μL binding buffer, then add 5 μL Annexin V-FITC and PI staining solution in sequence, incubate at room temperature for 5 minutes, and analyze the proportion of early and late apoptotic cells in macrophages by flow cytometry (Agilent NovoCyte).
2)试验结果2) Test results
1.芦荟松具有DPPH清除活性1. Aloe pine has DPPH scavenging activity
DPPH是一种稳定的有机自由基,在517nm处有一强吸收峰,抗氧化剂可与其单电子配对而使其吸收逐渐消失,吸光值的变化与其接受的电子数成定量关系,因而通过测定抗氧化剂对DPPH的清除能力了即可表示其抗氧化性的强弱。实验结果显示,芦荟松能很好地清除DPPH自由基,其IC
50为0.73,与天然抗氧化剂茶多酚的抗氧化活性相当。
DPPH is a stable organic free radical with a strong absorption peak at 517nm. Antioxidants can pair with their single electrons to make their absorption gradually disappear. The change of light absorption value has a quantitative relationship with the number of electrons they accept. The ability to scavenge DPPH can indicate the strength of its antioxidant activity. The experimental results show that aloe vera pine can scavenge DPPH free radicals very well, and its IC 50 is 0.73, which is equivalent to the antioxidant activity of natural antioxidant tea polyphenols.
表1.芦荟松体外DPPH自由基清除活性Table 1. Aloe pine in vitro DPPH free radical scavenging activity
2.芦荟松降低脂多糖诱导的巨噬细胞ROS水平2. Aloe pine reduces lipopolysaccharide-induced macrophage ROS level
DCFH-DA是一种通用的氧化应激指示剂。DCFH-DA本身没有荧光,可以自由穿过细胞膜,进入细胞后,可以被细胞内的酯酶水解生成DCFH(2',7'-Dichlorodihydrofluorescein,DCFH)。而DCFH不能通透细胞膜,从而使探针很容易被装载到细胞内。细胞内的活性氧可以氧化无荧光的DCFH生成有荧光的DCF。检测DCF的荧光以判定细胞内活性氧的水平。本研究通过 DCFH-DA观察芦荟松对脂多糖诱导的巨噬细胞活性氧的影响。结果表明,如图1所示,与正常培养的巨噬细胞相比,脂多糖处理RAW264.7细胞诱发ROS积累。而芦荟松能显著降低由脂多糖诱发的RAW264.7细胞ROS水平,且抑制效果呈现剂量依赖性。DCFH-DA is a general indicator of oxidative stress. DCFH-DA itself has no fluorescence and can freely pass through the cell membrane. After entering the cell, it can be hydrolyzed by intracellular esterase to generate DCFH (2',7'-Dichlorodihydrofluorescein, DCFH). However, DCFH cannot permeate the cell membrane, so the probe can be easily loaded into the cell. Intracellular reactive oxygen species can oxidize non-fluorescent DCFH to produce fluorescent DCF. The fluorescence of DCF was detected to determine the level of reactive oxygen species in the cells. In this study, DCFH-DA was used to observe the effect of aloe vera pine on macrophage reactive oxygen species induced by lipopolysaccharide. The results showed that, as shown in Figure 1, LPS treatment of RAW264.7 cells induced ROS accumulation compared with normally cultured macrophages. Aloe pine can significantly reduce the ROS level of RAW264.7 cells induced by lipopolysaccharide, and the inhibitory effect is dose-dependent.
3.芦荟松抑制脂多糖诱导的巨噬细胞凋亡3. Aloe pine inhibits lipopolysaccharide-induced macrophage apoptosis
细胞凋亡早期,细胞膜的不对称性消失,膜内磷脂酰丝氨酸转移到膜外,由FITC标记的膜联蛋白(Annexin V)能够与磷脂酰丝氨酸结合指示细胞凋亡早期;而另一种染色剂PI则能扩散至凋亡和坏死细胞的核内,并与DNA结合,用于指示凋亡晚期。In the early stage of apoptosis, the asymmetry of the cell membrane disappears, the phosphatidylserine in the membrane is transferred to the outside of the membrane, and the FITC-labeled annexin (Annexin V) can be combined with phosphatidylserine to indicate the early stage of apoptosis; while another staining The agent PI can diffuse into the nucleus of apoptotic and necrotic cells and combine with DNA to indicate the late stage of apoptosis.
本研究结果表明,如图2所示,与正常巨噬细胞相比,脂多糖诱导的巨噬细胞出现较多早期和晚期凋亡细胞,而应用10μM和100μM芦荟松进行干预后能显著降低早期凋亡(43.5%和28.6%)和晚期凋亡(58.9%和47.4%)的巨噬细胞比例。The results of this study showed that, as shown in Figure 2, compared with normal macrophages, lipopolysaccharide-induced macrophages had more early and late apoptotic cells, and the intervention of 10 μM and 100 μM aloe vera pine could significantly reduce the early apoptotic cells. Proportion of macrophages in apoptosis (43.5% and 28.6%) and late apoptosis (58.9% and 47.4%).
以上所述仅为本发明的较佳实施例而已,并不用以限制本发明,凡在本发明的精神和原则之内,所做的任何修改、等同替换、改进等,均应包含在本发明的保护范围之内。The above descriptions are only preferred embodiments of the present invention, and are not intended to limit the present invention. Any modifications, equivalent replacements, improvements, etc. made within the spirit and principles of the present invention shall be included in the present invention. within the scope of protection.
Claims (4)
- 芦荟松在制备抗氧化应激损伤产品中应用。Aloe pine is used in the preparation of anti-oxidative stress damage products.
- 根据权利要求1所述的应用,其特征在于,所述芦荟松通过清除ROS抑制巨噬细胞凋亡来抗氧化应激损伤。The application according to claim 1, characterized in that the aloe vera pine inhibits macrophage apoptosis by clearing ROS to resist oxidative stress damage.
- 根据权利要求1或2所述的应用,其特征在于,所述抗氧化应激损伤产品应用于制备预防或治疗氧化应激损伤诱发疾病药物。The use according to claim 1 or 2, characterized in that the anti-oxidative stress damage product is used in the preparation of drugs for the prevention or treatment of diseases induced by oxidative stress damage.
- 根据权利要求3所述的应用,其特征在于,所述药物还包括药学上接受的辅料。The use according to claim 3, characterized in that the medicament further comprises pharmaceutically acceptable auxiliary materials.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PCT/CN2021/115228 WO2023028730A1 (en) | 2021-08-30 | 2021-08-30 | Use of aloesone in preparation of product for resisting oxidative stress injury |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PCT/CN2021/115228 WO2023028730A1 (en) | 2021-08-30 | 2021-08-30 | Use of aloesone in preparation of product for resisting oxidative stress injury |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2023028730A1 true WO2023028730A1 (en) | 2023-03-09 |
Family
ID=85411722
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/CN2021/115228 WO2023028730A1 (en) | 2021-08-30 | 2021-08-30 | Use of aloesone in preparation of product for resisting oxidative stress injury |
Country Status (1)
Country | Link |
---|---|
WO (1) | WO2023028730A1 (en) |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20030207818A1 (en) * | 2002-05-03 | 2003-11-06 | Qi Jia | 7-Hydroxy chromones as potent antioxidants |
CN113768918A (en) * | 2021-08-30 | 2021-12-10 | 海南医学院 | Application of aloe floss in preparation of anti-oxidative stress injury products |
-
2021
- 2021-08-30 WO PCT/CN2021/115228 patent/WO2023028730A1/en unknown
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20030207818A1 (en) * | 2002-05-03 | 2003-11-06 | Qi Jia | 7-Hydroxy chromones as potent antioxidants |
CN113768918A (en) * | 2021-08-30 | 2021-12-10 | 海南医学院 | Application of aloe floss in preparation of anti-oxidative stress injury products |
Non-Patent Citations (3)
Title |
---|
HENG HUAY CHIN, ZULFAKAR MOHD HANIF, NG PEI YUEN: "Pharmaceutical applications of Aloe vera", INDONESIAN JOURNAL OF PHARMACY, vol. 29, no. 3, 1 January 2018 (2018-01-01), pages 101 - 116, XP093042492, ISSN: 2338-9427, DOI: 10.14499/indonesianjpharm29iss3pp101 * |
REZA NAZIFI S. MOHAMAD, ASGHARSHAMSI MOHAMMAD H., DEHKORDI MEHRDAD M., ZBOROWSKI KRZYSZTOF K.: "Antioxidant properties of Aloe vera components: a DFT theoretical evaluation", FREE RADICAL RESEARCH, vol. 53, no. 8, 3 August 2019 (2019-08-03), GB , pages 922 - 931, XP093042488, ISSN: 1071-5762, DOI: 10.1080/10715762.2019.1648798 * |
SALEHI BAHARE, ALBAYRAK SEVIL, ANTOLAK HUBERT, KRĘGIEL DOROTA, PAWLIKOWSKA EWELINA, SHARIFI-RAD MEHDI, UPRETY YADAV, TSOUH FOKOU P: "Aloe Genus Plants: From Farm to Food Applications and Phytopharmacotherapy", INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, vol. 19, no. 9, 19 September 2018 (2018-09-19), pages 1 - 49, XP093042486, DOI: 10.3390/ijms19092843 * |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Huang et al. | Antioxidative and anti-inflammatory activities of polyhydroxyflavonoids of Scutellaria baicalensis GEORGI | |
Cho et al. | Anti-cancer effect of cyanidin-3-glucoside from mulberry via caspase-3 cleavage and DNA fragmentation in vitro and in vivo | |
Yan et al. | The new synthetic H2S-releasing SDSS protects MC3T3-E1 osteoblasts against H2O2-induced apoptosis by suppressing oxidative stress, inhibiting MAPKs, and activating the PI3K/Akt pathway | |
Mbeunkui et al. | In vitro antiplasmodial activity of indole alkaloids from the stem bark of Geissospermum vellosii | |
Yang et al. | Phenolic compounds with radical scavenging and cyclooxygenase-2 (COX-2) inhibitory activities from Dioscorea opposita | |
Azadmehr et al. | Antioxidant and neuroprotective effects of scrophularia striata extract against oxidative stress-induced neurotoxicity | |
Peng et al. | Synthesis of novel caffeic acid derivatives and their protective effect against hydrogen peroxide induced oxidative stress via Nrf2 pathway | |
Tan et al. | Honokiol post-treatment ameliorates myocardial ischemia/reperfusion injury by enhancing autophagic flux and reducing intracellular ROS production | |
Song et al. | Puerarin protects against cadmium-induced proximal tubular cell apoptosis by restoring mitochondrial function | |
US10695285B2 (en) | Anti-pollution complex comprising calendula extracts and an aqueous extract of lilum candidum bulb and uses thereof | |
Sooknual et al. | Synthesis and neuroprotective effects of novel chalcone-triazole hybrids | |
CN108653276B (en) | Application of 3-aryl coumarin compound | |
CN106916161B (en) | A kind of isoamylene radical chromocor and its purposes in preparing treatment diseases associated with inflammation drug | |
US5928646A (en) | Process for extracting catechin polyphenols from potentillas, extract obtained and its use | |
Fabiani et al. | The production of hydrogen peroxide is not a common mechanism by which olive oil phenols induce apoptosis on HL60 cells | |
CN110831589A (en) | Medical compounds | |
WO2023028730A1 (en) | Use of aloesone in preparation of product for resisting oxidative stress injury | |
EP3116849A1 (en) | Compounds with a combined antioxidant activity against free radicals together with an anti-inflammatory action, and pharmaceutical and cosmetic compositions containing them for the treatment of skin and hair | |
CN113768918A (en) | Application of aloe floss in preparation of anti-oxidative stress injury products | |
Kapkoti et al. | Design and synthesis of novel glycyrrhetinic acid-triazole derivatives that exert anti-plasmodial activity inducing mitochondrial-dependent apoptosis in Plasmodium falciparum | |
CN102731459A (en) | Scutellarin aglycone Mannich derivatives, and preparation method and application thereof | |
WO2009102083A1 (en) | Novel clitocybin derivatives, preparation method thereof and composition containing the extract of clitocybe aurantiaca kctc 11143bp or the novel clitocybin derivatives for prevention of aging as an active ingredient | |
EP3274347A1 (en) | Compounds having antioxidant activity against free radicals and anti-inflammatory activity, and corresponding pharmaceutical or cosmetic compositions for skin care | |
Huang et al. | Involvement of nitrosative stress cytotoxicity induced by CdTe quantum dots in human vascular endothelial cells | |
US20240148816A1 (en) | Herbal composition comprising solanum nigrum for the treatment of cancer |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 21955315 Country of ref document: EP Kind code of ref document: A1 |
|
NENP | Non-entry into the national phase |
Ref country code: DE |